Sedentary time and markers of inflammation in people with newly diagnosed type 2 diabetes  by Falconer, C.L. et al.
Nutrition, Metabolism & Cardiovascular Diseases (2014) 24, 956e962Available online at www.sciencedirect.com
Nutrition, Metabolism & Cardiovascular Diseases
j ourna l homepage: www.e lsev ier .com/ locate/nmcdSedentary time and markers of inﬂammation in people with newly
diagnosed type 2 diabetes
C.L. Falconer a,b,*, A.R. Cooper a,b, J.P. Walhin c, D. Thompson c, A.S. Page a, T.J. Peters d,
A.A. Montgomery e,f, D.J. Sharp f, C.M. Dayan g, R.C. Andrews d
a Centre for Exercise, Nutrition and Health Sciences, School for Policy Studies, University of Bristol, UK
bNational Institute for Health Research Bristol Biomedical Research Unit in Nutrition, Diet and Lifestyle, University of Bristol, UK
cDepartment for Health, University of Bath, Bath, UK
d School of Clinical Sciences, University of Bristol, Bristol, UK
eNottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK
f School of Social and Community Medicine, University of Bristol, Bristol, UK
g Institute of Clinical Diabetes and Metabolism, Cardiff University School of Medicine, Cardiff, UKReceived 26 November 2013; received in revised form 18 March 2014; accepted 20 March 2014
Available online 26 April 2014KEYWORDS
Sedentary time;
Type 2 diabetes;
Breaks in sedentary
time;
Inﬂammation* Corresponding author. NIHR Biomed
Diet and Lifestyle, Level 3, University
Centre, Upper Maudlin Street, Brist
1173421759.
E-mail address: Catherine.falconer@b
0939-4753 ª 2014 Elsevier B.V.
http://dx.doi.org/10.1016/j.numecd.2014.03.009
Open access unAbstract Background and aims: We investigated whether objectively measured sedentary time
was associated with markers of inﬂammation in adults with newly diagnosed type 2 diabetes.
Methods and results: We studied 285 adults (184 men, 101 women, mean age 59.0  9.7) who had
been recruited to the Early ACTivity in Diabetes (Early ACTID) randomised controlled trial. C-
reactive protein (CRP), adiponectin, soluble intracellular adhesion molecule-1 (sICAM-1),
interleukin-6 (IL-6), and accelerometer-determined sedentary time and moderate-vigorous
physical activity (MVPA) were measured at baseline and after six-months. Linear regression anal-
ysis was used to investigate the independent cross-sectional and longitudinal associations of
sedentary time with markers of inﬂammation.
At baseline, associations between sedentary time and IL-6 were observed in men and women,
an association that was attenuated following adjustment for waist circumference. After 6 months
of follow-up, sedentary time was reduced by 0.4  1.2 h per day in women, with the change in
sedentary time predicting CRP at follow-up. Every hour decrease in sedentary time between
baseline and six-months was associated with 24% (1, 48) lower CRP. No changes in sedentary
time between baseline and 6 months were seen in men.
Conclusions: Higher sedentary time is associated with IL-6 in men and women with type 2 dia-
betes, and reducing sedentary time is associated with improved levels of CRP in women. Inter-
ventions to reduce sedentary time may help to reduce inﬂammation in women with type 2
diabetes.
ª 2014 Elsevier B.V. Open access under CC BY-NC-ND license.ical Research Unit in Nutrition,
Hospitals Bristol Education
ol BS2 8AE, UK. Tel.: þ44
ristol.ac.uk (C.L. Falconer).
der CC BY-NC-ND license.Introduction
Type 2 diabetes is one of the most prevalent chronic dis-
eases worldwide, contributing signiﬁcantly to the global
burden of disease [1]. Diabetes is an independent risk
factor for cardiovascular disease (CVD) and in people with
CVD, the presence of diabetes worsens prognosis [2].
Chronic inﬂammation is implicated in the pathogenesis of
type 2 diabetes and in the development of CVD and other
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Inﬂammatory cytokines secreted by adipose tissue are
involved in the regulation of glucose metabolism and in-
sulin resistance, and also in other inﬂammatory processes
linked to an increased CVD risk [4]. For example, high
levels of C-reactive protein (CRP) are related to risk of
future CVD in people with type 2 diabetes [5]. The in-
ﬂammatory nature of type 2 diabetes is partly mediated
through increased adiposity [6], with hepatic CRP secre-
tion suggested to increase in response to an adiposity-
related increase in another inﬂammatory cytokine,
interleukin-6 (IL-6). Adiposity is also associated
with reduced levels of adiponectin [7], an anti-
inﬂammatory cytokine with anti-atherogenic properties.
Other, non-adipose, markers of inﬂammation such as sol-
uble intracellular adhesion molecule-1 (sICAM-1), are
independently associated with risk of CVD and
provide information on the inﬂammatory state of the
vasculature [8].
Regular physical activity is a cornerstone in the pre-
vention and treatment of type 2 diabetes due to its actions
on glucose control, and blood pressure [9] and is also
known to reduce inﬂammation in people with type 2
diabetes [10], therefore providing a potential avenue for
intervention to reduce CVD risk. However, people with
type 2 diabetes have low levels of physical activity with
few meeting physical activity recommendations of 30 min
moderate to vigorous physical activity (MVPA) on ﬁve days
of the week [11]. There is increasing interest in the role
that sedentary behaviours may play in adult health. Higher
levels of time spent sedentary are associated with an
increased risk of type 2 diabetes, cardiovascular disease,
and cardiovascular and all-cause mortality [12,13], inde-
pendently of levels of physical activity. In addition, detri-
mental cross-sectional associations between sedentary
time objectively measured with accelerometers and waist
circumference, HDL-cholesterol and insulin resistance
have been shown in both healthy individuals [14] and
those with type 2 diabetes [15]. In adults with newly
diagnosed type 2 diabetes, MVPA accounts for 3.2% of the
day in contrast to 61.5% of the day spent sedentary [15],
and reducing sedentary time may thus provide an alter-
native approach to managing health status in such
individuals.
There is evidence that prolonged sedentary time may
impact upon inﬂammation [16,17]. However, the mecha-
nism by which this occurs and how much of the effect is
mediated through differences in MVPA and adiposity is not
well understood. Studies in healthy individuals or those at
risk of type 2 diabetes have demonstrated higher levels of
objectively measured sedentary time to be associated with
CRP, independently of MVPA [14,18,19], and one study re-
ported evidence of a sex difference, with self-reported
sitting time associated with inﬂammation in women, but
not men [20]. However, all associations were attenuated
when adjusted for BMI [20]. To date, no studies have
investigated the independent associations of objectively
measured sedentary time with inﬂammatory biomarkers
in individuals with type 2 diabetes.Therefore, the aim of the present study was to investi-
gate the sex-speciﬁc associations of objectively measured
sedentary time with selected inﬂammatory biomarkers in
individuals with newly diagnosed type 2 diabetes. If such
associations are present, they may indicate an alternative
route to improve health in people with type 2 diabetes.
Methods
Participants
This paper presents a secondary data analysis from the
Early ACTivity in Diabetes (Early ACTID) study, a rando-
mised controlled trial of physical activity and diet in the
management of type 2 diabetes. This study has been
described in detail previously [21]. Brieﬂy, participants
with newly diagnosed type 2 diabetes were recruited
through primary care in the South West of England.
Eligible participants had a clinical diagnosis of type 2
diabetes in the previous 6 months and were aged 30e80
years at diagnosis. Participants were excluded on the basis
of uncontrolled diabetes (HbA1c > 10% [85.8 mmol/mol]),
blood pressure > 180/100 mmHg, LDL-cholesterol
>4 mmol/l, and body mass index (BMI) < 25 kg/m2 or
body weight >180 kg. Telephone screening was performed
on 1634 participants, of whom 712 were eligible for face-
to-face screening and 593 were enrolled in the study. All
participants provided written informed consent prior to
participation and ethical approval was obtained from the
Bath Hospital Research Ethics Committee (05/Q2001/5).
This study is registered (number ISRCTN92162869).
Metabolic and anthropometric outcomes
Venous blood samples were obtained following an over-
night fast and analysis was conducted by individuals
blinded to the patient’s identity. Serum was analysed for
IL-6, sICAM-1 and adiponectin using commercially avail-
able solid phase ELISAs (Quantikine, R and D Systems Inc.,
Abingdon; US). High sensitivity serum CRP was deter-
mined using an automated high sensitivity immunoturbi-
dimetric assay and RX Daytona clinical chemistry analyser
(Randox Laboratories Ltd., UK). Average intra- and inter-
assay coefﬁcient of variation (CV) was established from the
repeated analysis of 20e60 samples at different concen-
trations. The intra-assay CV was 3%, 5%, 6% and 9% for CRP,
adiponectin, sICAM-1 and IL-6, respectively. The inter-
assay coefﬁcient of variation was 6e7% for all assays except
IL-6 which was 16%. Body weight and height were
measured to the nearest 0.1 kg and 0.5 cm, respectively
with participants wearing light, indoor clothing and
without shoes. Waist circumference was measured at the
midpoint between the lowest rib and anterior iliac. Social
deprivation was measured using the Index of Multiple
Deprivation (IMD) score, a measure of local area depriva-
tion that takes into account income, employment, health
and disability, education and training, housing and ser-
vices, living environment and crime, based on re-
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status, ethnicity and medication were obtained by the
research nurse.
Physical activity and sedentary time
Participants wore an uni-axial accelerometer (Actigraph
GT1M; Actigraph LLC, Pensacola, FL, USA) set to record
data every minute on a waist-worn belt for seven days
during waking hours except when swimming or bathing.
Accelerometer data were downloaded using Actilife soft-
ware (version 1.0.52 Actigraph LLC) and data were pro-
cessed using Kinesoft (version 3.3.62; Kinesoft, Saskatoon,
SK, Canada) to generate outcome variables (mean daily
physical activity, accelerometer counts per minute (cpm),
and daily minutes of MVPA and sedentary time). For
comparison with other studies, thresholds of 1952 cpm
for MVPA and <100 cpm for sedentary time were used to
compute the average number of minutes spent in each
behaviour [14,23]. Non-wear time was deﬁned as a period
of 20 min with continuous zero values, and days with at
least 10 h of measurement were considered valid. For in-
clusion in the analyses, participants were required to re-
cord at least three valid days of accelerometer data [15].
Medication was held constant between the baseline and 6
month assessments.
Statistical analyses
Since the Early ACTID intervention was not designed to
inﬂuence sedentary behaviour, data were treated as a
cohort and not analysed by trial arm. Descriptive charac-
teristics are summarised as mean and SD, unless otherwise
stated. Due to their skewed distribution, inﬂammatory
marker variables were log transformed and are presented
as geometric means. Sex differences in demographic,
physical activity and inﬂammatory variables were
explored using t-tests for continuous variables and the chi-
squared test for differences for categorical data. Paired
sample t-tests were used to describe differences in mean
values of continuous variables between baseline and 6
months. Linear regression analyses were used to explore
cross-sectional associations between sedentary time and
inﬂammatory variables at baseline. Regressions were per-
formed separately in males and females. Linear regression
models were built with total sedentary time as the expo-
sure and each inﬂammatory variable in turn as the
outcome. Model 1 was adjusted for age, current smoking
(yes/no), trial arm (diet, diet plus activity or usual care),
deprivation score, lipid, blood pressure or diabetes-
lowering medication (dichotomised as medication yes/
no), accelerometer wear time, and MVPA. Model 2 was
additionally adjusted for waist circumference. Linear
regression was used to examine whether a change in
sedentary time between baseline and 6 months predicted
the inﬂammatory variables at follow-up. Models were
adjusted as before, and also included baseline values of
sedentary time, change in MVPA and the baseline inﬂam-
matory variable under investigation. Interaction termswere used to test differences in the effect of sedentary
time by sex. CRP can be inﬂuenced by acute infection and
therefore a sensitivity analysis was conducted to explore
whether excluding high values (>10 mg/L) inﬂuenced the
outcome. All analyses were conducted using STATA 12
(College Station, TX; StataCorp). The signiﬁcance level was
set as p < 0.05 for all analysis and p < 0.1 for interaction
terms.
Results
A total of 593 patients were randomised to the Early-
ACTID study. Of these, 285 (48%) fulﬁlled the accelerom-
eter inclusion criteria, had complete inﬂammatory marker
proﬁles at baseline and 6 months and were included in the
present analyses. Participants who were included in the
analysis tended to be younger than those who had
incomplete data (58.9  9.7 years compared to 60.9  10.5
years) but there were no other differences in terms of BMI,
HbA1c, MVPA or sedentary time.
The baseline demographic, metabolic, inﬂammatory
and physical activity characteristics of the participants
are shown in Table 1 (n Z 285), overall and for each sex
separately. Men were more physically active than
women. No sex-related differences in total sedentary
time were observed. Females tended to be more obese
and had higher levels of sICAM-1, CRP and adiponectin
than males.
Table 2 shows the regression coefﬁcients for the cross-
sectional baseline associations between sedentary time
with markers of inﬂammation, adjusting for medication
status, trial arm, age, smoking, deprivation, accelerom-
eter wear time and MVPA. An association was seen be-
tween IL-6 and sedentary time in both men and women.
For every increased hour spent sedentary, IL-6 was lower
by 8% (95% CI 0, 15) in men and 12% (95% CI 0, 24) in
women. These associations were attenuated following
adjustment for waist circumference. No other associa-
tions between sedentary time and inﬂammatory markers
were seen. Removing MVPA from the models did not
substantially change the coefﬁcients and all models were
unaffected by replacement of BMI for waist circumfer-
ence. No associations between MVPA and markers of
inﬂammation were observed following adjustment for
confounders.
Changes in sedentary time and inﬂammatory markers
between baseline and 6 months are shown in Table 1.
Sedentary time was reduced in women only, decreasing by
0.4  1.2 h per day between baseline and 6 months. In
women, sICAM-1 had reduced by 7.9% (95% CI 14.3, 1.1)
after 6 months and reductions of 42.0% (95% CI 56.9,
22.1) in CRP were also seen. In men, the only inﬂam-
matory cytokine to change was adiponectin increasing by
23.6% (95% CI 12.4, 36.0) after 6 months. Daily MVPA
increased by 3.8  22.9 min between baseline and follow-
up in men, while no changes were seen in women.
Table 3 shows the longitudinal associations between
sedentary time and inﬂammatory outcomes at follow-up.
A change in sedentary time from baseline to 6 months
Table 1 Demographic, metabolic and inﬂammatory characteristics of participants at baseline and 6 months.
Characteristic Men Women Total P Valuea
n 184 101 285
Age (years) 59.8  9.3 57.5  10.3 59.0  9.7 0.064
BMI (kg/m2) 30.6  4.8 33.5  7.0 31.6  5.8 <0.001
Waist circumference (cm) 107.6  11.4 105.0  14.9 106.7  12.8 0.103
Ethnicity (% white) 97.8 96.0 97.2 0.382
Family history diabetes (%) 45.1 64.4 51.9 0.002
Current smoker (%) 5.0 8.2 7.0 0.311
Deprivation index 14.3  10.0 16.9  12.6 16.5  15.2 0.052
Time since diagnosis (days) 147.0  52.4 145.0  49.4 146.3  51.3 0.747
HbA1c (%) 6.6  1.0 6.8  1.1 6.7  1.0 0.086
On diabetes medication (%) 33.7 41.6 36.5 0.186
On lipid medication (%) 66.3 51.5 61.1 0.014
On BP medication (%) 59.8 64.4 61.4 0.448
Inﬂammatory markersb
sICAM-1 (ng/ml)
Baseline 240.4 (232.9, 248.2) 266.3 (254.3, 278.4) 253,5 (246.5, 260.7) 0.005
6 months 238.8 (229.3, 248.8) 239.2 (227.0, 251.9) 248.6 (239.4, 257.7) 0.968
Difference 0.7 (5.0, 4.4) 7.9 (14.3, 1.1) 3.3 (7.2, 0.7)
IL-6 (pg/ml)
Baseline 2.4 (2.0, 2.9) 2.4 (2.1, 2.7) 2.4 (2.1, 2.7)
6 months 2.0 (1.8, 2.2) 2.0 (1.8, 2.2) 2.0 (1.9, 2.2) 0.658
Difference 4.8 (17.7, 33.4) 1.3 (14.6, 20.1) 4.9 (4.8, 15.4) 0.792
CRP (mg/L)
Baseline 1.6 (1.4, 1.9) 3.2 (2.6, 3.9) 3.7 (3.2, 4.3)
6 months 1.7 (1.4, 2.0) 1.8 (1.5, 2.3) 1.7 (1.5, 2.0) <0.001
Difference 6.9 (5.0, 20.1) 42.0 (56.9, 22.1) 15.1 (29.7, 2.7) 0.552
Adiponectin (mg/ml)
Baseline 4.4 (4.1, 4.7) 5.9 (5.3, 6.5) 5.5 (5.2, 5.9) <0.001
6 months 5.4 (5.1, 5.9) 5.2 (4.7, 5.8) 5.4 (5.1, 5.7) 0.557
Difference 23.6 (12.4, 36.0) 10.4 (21.9, 2.6) 10.4 (1.9, 19.5)
Physical activity
MVPA (min/day)
Baseline 29.6  20.7 20.7  16.4 26.4  19.7 <0.001
6 months 33.4  24.1 21.3  18.6 29.1  23.0 <0.001
Difference 3.8  22.9 0.64  14.3 2.7  20.3
Sedentary time (h/day)
Baseline 7.9  1.3 8.1  1.1 8.0  1.2
6 months 7.7  1.5 7.6  1.2 7.7  1.4 0.315
Difference 0.2  1.5 0.4  1.2 0.3  1.4 0.640
Accelerometer wear time (days)
Baseline 4.5  0.7 4.6  0.6 4.5  0.67 0.093
6 months 4.4  0.8 4.5  0.7 4.4  0.8 0.425
Accelerometer wear time (hours/day)
Baseline 12.9  1.0 13.0  1.0 12.9  1.0 0.398
6 months 12.6  1.1 12.6  0.9 12.6  1.0 0.776
Results are presented as means  SD, and number (column percentages).
a P value for differences between men and women. Signiﬁcance level, p < 0.05.
b Inﬂammatory markers are displayed as geometric means  SD with differences between baseline and 6 months are presented as ratios of the
geometric means.
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1 h in sedentary time being associated with a 24% (95% CI
1.0, 48.0) reduction in CRP in women, with no associations
seen in men.
Regression models containing appropriate interaction
terms provided some evidence that any associations be-
tween sedentary time and CRP differed for men and
women (Table 2). There was also evidence of an interac-
tion by sex for the relationship between a change in
sedentary time and CRP (Table 3). All results were unaf-
fected if participants with a CRP >10 mg/L (n Z 17) were
excluded from the analysis, data not shown.Discussion
This study investigated the cross-sectional and longitudi-
nal associations between total sedentary time and markers
of inﬂammation in a sample of adults with newly diag-
nosed type 2 diabetes enrolled in the Early ACTID diet and
lifestyle randomised controlled trial. Independent cross-
sectional associations between total sedentary time and
IL-6 were seen in men and women; however, all associa-
tions were attenuated following adjustment for waist
circumference. At 6 months follow-up, adiponectin had
increased in men compared to baseline and sICAM-1 and
Table 2 Cross-sectional linear regression analysis of the associations of sedentary time with inﬂammatory variables in the full baseline sample.
Sedentary time Interaction terms
Men (n Z 184) Women (n Z 101) B (95% CI) P value
b (95% CI) P value b (95% CI) P value
Log sICAM-1 (ng/ml)a
Model 1 0.01 (0.04, 0.02) 0.642 0.01 (0.05, 0.04) 0.751
Model 2 0.01 (0.04, 0.02) 0.336 0.02 (0.07, 0.03) 0.409 0.03 (0.01, 0.08) 0.171
Log IL-6 (pg/ml)a
Model 1 0.08 (0.00, 0.15) 0.049 0.12 (0.00, 0.24) 0.043
Model 2 0.07 (0.01, 0.14) 0.097 0.08 (0.05, 0.20) 0.228 0.04 (0.17, 0.08) 0.483
Log CRP (mg/L)a
Model 1 0.05 (0.09, 0.19) 0.485 0.16 (0.05, 0.36) 0.129
Model 2 0.02 (0.11, 0.16) 0.768 0.06 (0.14, 0.27) 0.537 0.25 (0.47, 0.03) 0.025
Log adiponectin (mg/ml)a
Model 1 0.00 (0.07, 0.06) 0.937 0.08 (0.17, 0.02) 0.110
Model 2 0.00 (0.06, 0.07) 0.979 0.05 (0.15, 0.05) 0.322 0.02 (0.08, 0.11) 0.724
Regression results are presented as unstandardized coefﬁcients (b) (95% CI) All models are adjusted for age, trial arm, smoking, deprivation score,
lipid, glucose or blood pressure lowering medication, accelerometer wear time and MVPA. Model 2 is additionally adjusted for waist circum-
ference. Interaction terms were performed on model 2.
a Indicates exponentiated regression coefﬁcients interpreted as proportionate change in outcome for 1 unit change in sed time.
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also changed with men increasing MVPA and women
reducing sedentary time. Longitudinal associations were
demonstrated between a change in sedentary time and
follow-up CRP in women. All associations were indepen-
dent of MVPA. Our results build on accumulating evidence
to show the detrimental health effects of prolonged
sedentary time [15,18]. To our knowledge, these results are
the ﬁrst to show the harmful effects of sedentary time on
inﬂammation in adults with newly diagnosed type 2
diabetes.
This study has several strengths. The study included a
relatively large number of adults with newly diagnosed
type 2 diabetes. A range of outcome measures including
metabolic health, lifestyle behaviours, inﬂammatory
markers and potential confounders including medication
status, smoking, and age were collected. Sedentary time
was measured objectively using accelerometers. There are
also limitations within this study. The observational nature
of the analysis means causality cannot be inferred and
there is a possibility of residual confounding by other
factors, for example dietary intake while sedentary. The
analysis was performed separately by sex to allow for
differences in the sedentary behaviours as a result of theTable 3 Longitudinal linear regression analysis of the association of sede
Variable D SED between 0 and 6 months
Men B (95% CI) P value Wom
sICAM-1 (ng/ml) 0.02 (0.01, 0.06) 0.220 0.01 (
IL-6 (pg/ml) 0.07 (0.00, 0.16) 0.081 0.08 (
CRP (mg/L) 0.05 (0.11, 0.21) 0.541 0.24 (
Adiponectin (mg/ml) 0.03 (0.04, 0.09) 0.397 0.02 (
Regression results are presented as unstandardized coefﬁcients (B) (95% CI)
WC, relevant lipid, glucose or blood pressure lowering medication, baselin
MVPA.intervention. There was a suggestion of a possible sex-by-
sedentary time interaction for CRP with women exhibiting
a greater increase in CRP per unit increase in sedentary
time. However, the large discrepancy in sample size be-
tween males and females makes meaningful comparisons
between sexes difﬁcult.
Although accelerometers offer increased accuracy
compared to self-report, they have a number of limitations
for the measurement of sedentary time. Whilst the
thresholds used to deﬁne MVPA measured with the Acti-
graph accelerometer in adults are well deﬁned, a range of
thresholds have been used to deﬁne sedentary time
[18,20,23]. In addition, the criteria used in data reduction
procedures to discard continuous periods of zero values,
generally interpreted as time when the accelerometer has
been removed, commonly range between 20 and 60 min.
Since sedentary time is deﬁned as <100 cpm, and esti-
mates therefore include zero as a ‘real’ value, these de-
cisions may impact upon the measured volume of
sedentary time. Such methodological differences limit the
potential for comparisons across studies. The thresholds
for sedentary time and handling of zero values used in the
current study were selected to allow comparison with the
AusDiab data [23]. A further limitation of waist-wornntary time with inﬂammatory variables.
Interaction terms
en B (95% CI) P value b P value
0.05, 0.01) 0.723 0.01 (0.06, 0.05) 0.795
0.03, 0.20) 0.155 0.02 (0.14, 0.11) 0.801
0.01, 0.48) 0.043 0.23 (0.47, 0.00) 0.054
0.10, 0.13) 0.740 0.01 (0.10, 0.11) 0.890
. All models are adjusted for age, trial arm, smoking, deprivation score,
e sedentary time, change in accelerometer wear time, and change in
Sedentary time and inﬂammation in people with type 2 diabetes 961accelerometers in the measurement of sedentary time is
their inability to differentiate between postures, and po-
tential for misclassifying standing time as sedentary, since
sedentary behaviour is deﬁned as “any waking behaviour
characterised by an energy expenditure of less than or
equal to 1.5 metabolic equivalents while in a sitting or
reclining posture” [24]. To quantify the association between
sedentary time and health outcomes precisely, more ac-
curate measurement of sedentary time is required.
The inﬂammatory proﬁles of participants in the present
study were indicative of low-grade inﬂammation [25].
Women had heightened inﬂammation, as indicated by
elevated CRP, sICAM-1 and IL-6 compared to men. This is
in agreement with previous studies who have also
observed associations between sedentary time and
adverse health outcomes in women only [20,26]. Previous
studies have suggested that the physical activity patterns
of men, who tend to do more MVPA than women, may
offer protection against the detrimental health effects of
sedentary time [20]. Poor dietary behaviours such as
snacking are known to co-vary with time spent sedentary,
and there are suggestions of a more consistent association
in women [27]. More research is needed to understand the
dietary implications of prolonged sedentary time, and how
these might vary by sex.
The Early ACTID intervention did not speciﬁcally target
sedentary behaviours. However, women in the cohort
achieved an average reduction of sedentary time of
24 min/day after 6 months follow-up and furthermore the
change in sedentary time was associated with CRP such
that for every hour reduction in sedentary time, CRP was
reduced by 24%. It has been suggested that improvements
in IL-6 and CRP following lifestyle intervention are
dependent upon increases in MVPA [28], or reductions in
weight [29]. However, CRP was reduced at 6 months
compared to baseline in women, despite no changes in
MVPA and the addition of change in MVPA or weight into
the regression model did not attenuate the observed as-
sociations. This ﬁnding further strengthens the cross-
sectional associations between breaks in sedentary time
and CRP observed in the NHANES cohort that were inde-
pendent of time spent in MVPA [14]. The health beneﬁts of
MVPA are well documented and for people with type 2
diabetes include beneﬁcial effects on lipid proﬁles, glucose
control and inﬂammation [9]. However, people with type 2
diabetes commonly exhibit low levels of physical activity
and interventions to increase MVPA often fail to achieve
levels suggested to confer metabolic beneﬁts [21]. In the
current study, sedentary behaviour accounted for over 60%
of the participants waking day [21], and plausible physi-
ological mechanisms exist to explain the association be-
tween prolonged sedentary time and CRP [30]. The
accumulating evidence of the detrimental health effects of
prolonged sedentary time suggest targeting sedentary
time may be an alternative strategy for improving the
health of people with type 2 diabetes. These types of in-
terventions may be particularly beneﬁcial for women, who
have a heightened state of inﬂammation and CVD risk and
who may ﬁnd increasing MVPA more difﬁcult.In conclusion, our data suggest that in women with
newly diagnosed type 2 diabetes, sedentary behaviour can
have a harmful effect on markers of inﬂammation which
may be important for future risk of CVD. Inﬂammatory
proﬁles were improved following 6 months of lifestyle
intervention, with a change in sedentary time predictive of
a change in CRP for the women only, a ﬁnding that war-
rants further investigation. These ﬁndings suggest that
interventions to reduce sedentary time should be explored
as potential ways to reduce chronic inﬂammation in
women with type 2 diabetes. The incorporation of rec-
ommendations for reducing sedentary time into national
guidelines would provide further impetus for the devel-
opment of interventions to reduce sedentary time.
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